Cargando…
Development of a multivariable risk model integrating urinary cell DNA methylation and cell‐free RNA data for the detection of significant prostate cancer
BACKGROUND: Prostate cancer exhibits severe clinical heterogeneity and there is a critical need for clinically implementable tools able to precisely and noninvasively identify patients that can either be safely removed from treatment pathways or those requiring further follow up. Our objectives were...
Autores principales: | Connell, Shea P., O'Reilly, Eve, Tuzova, Alexandra, Webb, Martyn, Hurst, Rachel, Mills , Robert, Zhao, Fang, Bapat, Bharati, Cooper, Colin S., Perry, Antoinette S., Clark, Jeremy, Brewer, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383590/ https://www.ncbi.nlm.nih.gov/pubmed/32153047 http://dx.doi.org/10.1002/pros.23968 |
Ejemplares similares
-
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
por: Zhao, Fang, et al.
Publicado: (2018) -
Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy
por: Connell, Shea P., et al.
Publicado: (2021) -
A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
por: O’Connell, Shea P., et al.
Publicado: (2022) -
Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer
por: Yazbek Hanna, Marcelino, et al.
Publicado: (2023) -
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
por: O’Reilly, Eve, et al.
Publicado: (2019)